Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A
Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A Speaker(s): Dr. Jonathan Roberts NHF's Wednesday Webinars are a free education series open to…
Research Grant Recruitment
Research Grant Recruitment Speaker(s): Samantha Carlson, LMSW NHF's Wednesday Webinars are a free education series open to providers and community members. Register to attend and learn about the latest in…
Fishing for answers to hemostatic and thrombotic disease: Genome editing in zebrafish
Fishing for answers to hemostatic and thrombotic disease: Genome editing in zebrafish Speaker(s): Dr. Jordan Shavit NHF's Wednesday Webinars are a free education series open to providers and community members.…
NHF & HFA Respond to New Blue Cross Blue Shield of Tennessee Formularies
FOR IMMEDIATE RELEASE Contact: Ilana Ostrin 212-328-3769 On January 1st, Blue Cross Blue Shield of Tennessee (BCBST) implemented formularies for their health plans (individual, small group, and large group) that remove 17+…
The Need for Menstrual Research
On Wednesday, February 1, attend a presentation on the need for menstrual research and learn about an important new survey. Marybec Griffin, PhD, MA, MPH, will be presenting. Register for the webinar for free here. …
Understanding Clinical Trials
Clinical trials are one of the most important parts of the research process to find new ways to treat diseases. But this critical work is not possible without people like you.Understanding clinical trialsDuring clinical trials, new or improved…
What to Expect
What to expect before you start a trial Participating in a clinical trial can be a large commitment, so it’s important to know what to expect in advance. Depending on the goals of the trial, you might need to plan for more frequent visits to the…
Understanding Consent
What is the consent process?A clinical trial consent process uses a lengthy document called an informed consent form that explains everything you need to understand before deciding to sign up for a clinical trial. It will help you understand every…
NHF Responds to FDA's Proposed Blood Donation Changes
FOR IMMEDIATE RELEASE Contact: Ilana Ostrin 212-328-3769 Today, the United States Food and Drug Administration (FDA) announced proposed changes to blood donation policies that will likely take effect later this year. The policy…
Sanofi Announces New Efanesoctocog alfa Data Published in the NEJM
Sanofi recently announced newly published clinical trial data for efanesoctocog alfa, the company’s investigational recombinant factor VIII therapy (rFVIII) for the prevention of bleeding episodes in hemophilia A patients via once weekly…